Global Guillain-Barré Syndrome Therapeutics Market 2019-2023
- Published: Nov 2018
- Pages: 109
- SKU: IRTNTR30224
Enjoy complimentary customisation on priority with our Enterprise License!
Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
The global Guillain-Barré syndrome therapeutics market is forecasted to experience a meteoric rise by 2023 driven by the increasing number of strategic alliances between GB syndrome therapeutic companies. Wondering how to make the most of this flourishing GBS treatment industry? Technavio’s extensive industry research report offers detailed insights that will allow you to take full advantage of the opportunities available to you. This study provides an extensive analysis by considering the evolving demographics and consumer behavior in the global Guillain-Barré syndrome therapeutics market. It also examines the competitive landscape and some key GB syndrome therapeutic companies including CSL, Grifols, and Kedrion.
Below are some of the key findings from this GB syndrome therapeutics industry analysis report
The global Guillain-Barré syndrome therapeutics market is expected to grow at a CAGR of more than 5% during the forecast period
GB syndrome treatment industry growth is expected to accelerate over the next five years, driven by the recent approvals of immunoglobulins for the treatment of Guillain-Barré syndrome. Immunoglobulins are considered as the first line of treatment for Guillain-Barré syndrome and the market is forecasted to witness a rapid growth owing to the recent approvals of novel immunoglobulins from regulatory bodies. Guillain-Barré syndrome is regarded as a rare disorder, and the prevalence of the disease is much lower than other mainstream indicators such as diabetes and hypertension, which is compelling regulatory bodies to award special drug designations such as the orphan drug and fast track designations. Technavio’s GBS treatment industry analysis reveals promising markets around the world.
Get a FREE Sample of this report now!
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
The Americas dominated the Guillain-Barré syndrome therapeutics market by region
The global GB syndrome treatment market was dominated by the Americas with over 40% of the global market share, followed by EMEA and APAC. In addition, the Americas will drive almost two-fifths of the growth for the global GBS treatment industry, while EMEA and APAC are also predicted to contribute significantly to the incremental growth in the forecast period. The global GB syndrome treatment market will witness APAC registering the fastest rate of growth during the forecast period, while EMEA will generate a higher CAGR than the Americas.
CSL, Grifols, and Kedrion are some of the key GB syndrome therapeutic companies
The global GB syndrome treatment market is forecasted to become reasonably fragmented with the emergence of many international and regional GBS treatment companies who offer therapeutics such as immunoglobulins and other therapeutics. Pharmaceutical companies are working together for the development of medications for the treatment of Guillain-Barré syndrome, which is expected to enhance the R&D activities of new drugs for the management of GB syndrome. Many established GB syndrome therapeutic companies are vying for their share of the global GBS treatment market, and the new players must differentiate themselves to gain vital traction over their peers.
This report offers a complete analysis of several GB syndrome therapeutic companies, including:
- CSL
- Grifols
- Kedrion
- Octapharma
- Shire
Want to dial in on a specific region or segment? We can help! Our analysts can customize this report to meet your requirements. Get in touch
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Immunoglobulins - Market size and forecast 2018-2023
- Other therapeutics - Market size and forecast 2018-2023
- Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 11: TRENDS
PART 12: VENDOR LANDSCAPE
- Overview
- Landscape disruption
- Competitive scenario
PART 13: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- CSL
- Grifols
- Kedrion
- Octapharma
- Shire
PART 14: APPENDIX
- Research methodolog
- List of abbreviations
PART 15: EXPLORE TECHNAVIO
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases

DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts

REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
Certified ISO 9001 : 2015

We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.

We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.

Single:
One user only.
Quick & easy download optionEnterprise:
Unlimited user access (Within your organization)
Complimentary Customization Included
2500 USD
Get the report (PDF) sent to your email within minutes.
Subscribe & Save
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
- Our analysts will work directly with you and understand your needs
- Get data on specified regions or segments, competitor and Vendors
- Data will be formatted and presented as per your requirements
- We offer $1000 worth of FREE customization at the time of purchase
Let us help you make report more suited to your requirements.
- Get a competitive breakdown as per your niche industry
- Customize the data with various metrics that meet your business prerequisite
- Understand Revenue Sources, Customers and many more
- Details on Market Share
- These customizations are done in a short amount of time by our analysts and industry experts
